Validation of the YEARS algorithm in COVID-19 and Development and Validation of a decision support agent in a clinical AI system

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036056

Enrollment

100

Registered

2025-02-10

Start date

2021-06-04

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.2

Interventions

Group 1: Patients with and without COVID-19 and Presentation at the LMU Klinikum, Evaluation for pulmonary embolism and Validation of various AI based decision support agents using Large Language Mode

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients treated between 02/2020-12/2024 at the LMU Klinikum Munich

Exclusion criteria

Exclusion criteria: Patients presenting in the recovery phase at admission

Design outcomes

Primary

Measure	Time frame
The primary endpoint is diagnosis of pulmonary embolism	—

Secondary

Measure	Time frame
(1) overall survival, (2) occurrence of PE during the hospital stay for hospitalized COVID-19 patients, (3) COVID-19 disease stage (Table 1), performance of the diagnostic tools including artificial intelligence	—

Countries

Germany

Contacts

Public ContactHans Christian Stubbe

LMU Klinikum München, Medizinische Klinik II

Hans_Christian.Stubbe@med.uni-muenchen.de+4944000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026